Takatsuka Daiki, Ogura Hiroyuki, Asano Yuko, Nakamura Akiko, Koizumi Kei, Shiiya Norihiko, Baba Satoshi
First Department of Surgery, Hamamatsu University School of Medicine, 1-20-1 Handayama, Higashi-ku, Hamamatsu, Shizuoka, 431-3192, Japan.
Department of Pathology, Hamamatsu University Hospital, 1-20-1 Handayama, Higashi-ku, Hamamatsu, Shizuoka, 431-3192, Japan.
Surg Case Rep. 2021 Jan 12;7(1):16. doi: 10.1186/s40792-021-01110-0.
Fibromatosis-like metaplastic carcinoma (FLMCa), classified as a metaplastic carcinoma of the breast, is a very rare type of metaplastic carcinoma. We report a case of FLMCa that was difficult to diagnose.
The patient was a 56-year-old postmenopausal woman who presented with a left-sided breast mass. A 1.3-cm irregular mass was found in the lower outer quadrant of the left breast on breast ultrasonography. She underwent core needle biopsy and vacuum-assisted biopsy, but the pathological findings only revealed inflammatory cell infiltration and a high level of fibrosis, with no malignant findings. At 3 months follow-up, she underwent a repeat breast ultrasonography, which revealed an increase in the size of the mass to 1.8 cm, and a repeat core needle biopsy, which showed a few spindle cells and squamous cells positive for cytokeratin (CK)5/6 and AE1/AE3, leading to the suspicion of FLMCa. Since the amount of tissue was insufficient to establish a definitive diagnosis, she underwent a lumpectomy. We found low-grade and slightly atypical spindle cells and partly atypical spindle cell carcinoma and squamous cell carcinoma. CK5/6 and α-SMA were positive, thus confirming FLMCa. Because the margins on the edge of the nipple side and anterior side were "ink on tumor", she underwent a mastectomy and sentinel lymph node biopsy. After the surgery, she received adjuvant chemotherapy. At 3 years and 8 months of follow-up, no recurrent or metastatic lesions were identified in her body.
FLMCa should be considered in the differential diagnosis when collagenous fibers are proliferating and malignancy is clinically suspected. Immunohistochemical analysis may be helpful in confirming this diagnosis.
纤维瘤样化生癌(FLMCa)被归类为乳腺化生癌,是一种非常罕见的化生癌类型。我们报告一例难以诊断的FLMCa病例。
患者为一名56岁的绝经后女性,出现左侧乳腺肿块。乳腺超声检查发现左乳房外下象限有一个1.3厘米的不规则肿块。她接受了粗针活检和真空辅助活检,但病理结果仅显示炎性细胞浸润和高水平纤维化,未发现恶性病变。在3个月的随访中,她接受了重复乳腺超声检查,结果显示肿块大小增加到1.8厘米,并进行了重复粗针活检,结果显示一些梭形细胞和鳞状细胞细胞角蛋白(CK)5/6和AE1/AE3呈阳性,怀疑为FLMCa。由于组织量不足以确诊,她接受了肿块切除术。我们发现了低级别且轻度非典型的梭形细胞以及部分非典型梭形细胞癌和鳞状细胞癌。CK5/6和α-SMA呈阳性,从而确诊为FLMCa。由于乳头侧边缘和前侧边缘的切缘为“肿瘤墨染”,她接受了乳房切除术和前哨淋巴结活检。手术后,她接受了辅助化疗。在随访3年8个月时,未发现体内有复发或转移病灶。
当出现胶原纤维增生且临床怀疑有恶性病变时,鉴别诊断中应考虑FLMCa。免疫组织化学分析可能有助于确诊。